Literature DB >> 8463684

The economic impact of infected total joint arthroplasty.

T P Sculco.   

Abstract

Infection in total joint replacement is a devastating and life-threatening complication for the patient. It can also be an economic disaster for hospitals that treat large numbers of these patients. The most important factor in both the clinical and economic area is to prevent the infection from occurring at all. However, once deep infection is established, rapid, aggressive, and definitive treatment must be rendered to the patient. A method of case-sharing must be established by medical centers that are best equipped to care for these patients. Reimbursement to hospitals and physicians must more realistically reflect the magnitude of resources consumed by these patients and the time-consuming and intensive care provided by a team of physicians.

Entities:  

Mesh:

Year:  1993        PMID: 8463684

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN: 0065-6895


  37 in total

1.  Implementing an intensified antibiotic stewardship programme targeting daptomycin use in orthopaedic surgery: a cost-benefit analysis from the hospital perspective.

Authors:  Johannes P Borde; Sarah Nussbaum; Stefanie Hauser; Philip Hehn; Johannes Hübner; Gabriela Sitaru; Sebastian Köller; Bruno Schweigert; Katja deWith; Winfried V Kern; Klaus Kaier
Journal:  Infection       Date:  2015-10-16       Impact factor: 3.553

2.  Definition of periprosthetic joint infection: is there a consensus?

Authors:  Javad Parvizi; Christina Jacovides; Benjamin Zmistowski; Kwang Am Jung
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

3.  Traffic in the operating room during joint replacement is a multidisciplinary problem.

Authors:  Martin Bédard; Rémi Pelletier-Roy; Mathieu Angers-Goulet; Pierre-Alexandre Leblanc; Stéphane Pelet
Journal:  Can J Surg       Date:  2015-08       Impact factor: 2.089

4.  Diagnosis of prosthetic joint infections using UMD-Universal Kit and the automated multiplex-PCR Unyvero i60 ITI(®) cartridge system: a pilot study.

Authors:  Johannes P Borde; Georg A Häcker; Sina Guschl; Annerose Serr; Tobias Danner; Johannes Hübner; Sandra Burrack-Lange; Gerd Lüdke; Peter Helwig; Oliver Hauschild; Winfried V Kern
Journal:  Infection       Date:  2015-05-29       Impact factor: 3.553

5.  A novel technique to preserve range of motion in two-stage revision of infected total knee arthroplasty.

Authors:  Christian Carulli; Marco Villano; Roberto Civinini; Fabrizio Matassi; Lorenzo Nistri; Massimo Innocenti
Journal:  Int Orthop       Date:  2013-04-16       Impact factor: 3.075

6.  Primary vs Conversion Total Hip Arthroplasty: A Cost Analysis.

Authors:  Garwin Chin; David J Wright; Nimrod Snir; Ran Schwarzkopf
Journal:  J Arthroplasty       Date:  2015-08-29       Impact factor: 4.757

7.  Six weeks antibiotic therapy for all bone infections: results of a cohort study.

Authors:  R Farhad; P-M Roger; C Albert; C Pélligri; C Touati; P Dellamonica; C Trojani; P Boileau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-10       Impact factor: 3.267

8.  Risk Adjustment Is Necessary in Value-based Outcomes Models for Infected TKA.

Authors:  P Maxwell Courtney; Anthony J Boniello; Craig J Della Valle; Gwo-Chin Lee
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

9.  Direct exchange endoprosthetic reconstruction with tumour prosthesis for periprosthetic knee infection associated with segmental bone defects.

Authors:  Manjunath Ramappa; Ian McMurtry; Andrew Port
Journal:  Strategies Trauma Limb Reconstr       Date:  2010-01-12

Review 10.  Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach.

Authors:  Esa Jämsen; Ioannis Stogiannidis; Antti Malmivaara; Jorma Pajamäki; Timo Puolakka; Yrjö T Konttinen
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.